Evaluation and Management of Premature Grey Hair in Children

Genetic and Syndromic Causes

Children who present with premature greying plus nail or skin changes, sensorineural hearing loss, signs of early aging, or pulmonary/hepatic symptoms should be screened for TERT/TERC mutations, which are linked to systemic manifestations such as cirrhosis, pulmonary fibrosis, emphysema, and early‑aging features.  [**National Comprehensive Cancer Network**] [1]
TERT/TERC mutation carriers have a substantially increased risk of head and neck cancers, anogenital cancers, and skin cancer, necessitating lifelong cancer surveillance. [**National Comprehensive Cancer Network**] [1]
Fanconi anemia and dyskeratosis congenita (FANC gene mutations) may also cause premature greying and are typically accompanied by dysmorphic facial features, short stature, nail/skin abnormalities, thumb hypoplasia, and pulmonary fibrosis. [**National Comprehensive Cancer Network**] [1]

Thyroid dysfunction is a critical, treatable cause of premature greying and should be evaluated in every affected child because thyroid disease directly interferes with melanocyte pigment production. [British Association of Dermatology] [2]
Recommended endocrine labs include TSH, free T4, and anti‑thyroglobulin antibodies as part of the diagnostic work‑up. [British Association of Dermatology] [2]
Correcting identified thyroid abnormalities can lead to reversal of premature greying. [British Association of Dermatology] [2]

Vitamin D₃ deficiency shows the strongest association with premature greying in children; supplementation should follow general international pediatric dosing guidelines, with maintenance therapy for chronic deficiency. [British Association of Dermatology] [2]

A complete blood count with hemoglobin is recommended for all children with premature greying to screen for underlying hematologic or nutritional disorders. [**National Comprehensive Cancer Network**] [3]

The National Comprehensive Cancer Network recommends considering TERT/TERC mutations in children with premature graying, nail and skin changes, sensorineural deafness, and signs of early aging, as these patients have increased risk for head and neck cancers, anogenital cancers, and skin cancer 4

The British Journal of Dermatology suggests that thyroid dysfunction should be considered in children with premature graying, as thyroid disease associates with hair pigmentation changes 5

The National Comprehensive Cancer Network recommends a diagnostic approach that includes clinical history, physical examination, and laboratory evaluation, including serum ferritin, vitamin B12, vitamin D3, and serum calcium levels, as well as thyroid function tests if thyroid disease is suspected 4, 5

The National Comprehensive Cancer Network recommends considering genetic testing for TERT/TERC mutations in children with premature graying and associated symptoms, such as nail and skin changes, sensorineural deafness, and family history of early-onset cancers 4

Temporary hair colorants remain the most frequently employed cosmetic method for premature greying, but they are associated with risks such as allergic reactions, scalp inflammation, and paradoxical hair loss. Camouflage cosmetics and fake‑tanning products can also be offered to patients who prefer to avoid active pharmacologic treatments, as reported by the British Journal of Dermatology (2008) — low‑level evidence (expert opinion/case report) 6